The Myeloid-specific Sialic Acid-binding Receptor, CD33, Associates with the Protein-tyrosine Phosphatases, SHP-1 and SHP-2
Open Access
- 1 April 1999
- journal article
- Published by Elsevier
- Vol. 274 (17) , 11505-11512
- https://doi.org/10.1074/jbc.274.17.11505
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Specificity of the N-Terminal SH2 Domain of SHP-2 Is Modified by a Single Point MutationBiochemistry, 1998
- Regulation through inhibitory receptors: Lessons from natural killer cellsTrends in Cell Biology, 1997
- Differential association of phosphatases with hematopoietic co‐receptors bearing immunoreceptor tyrosine‐based inhibition motifsEuropean Journal of Immunology, 1997
- CD22, A B LYMPHOCYTE–SPECIFIC ADHESION MOLECULE THAT REGULATES ANTIGEN RECEPTOR SIGNALING*Annual Review of Immunology, 1997
- Molecular cloning of a novel gene similar to myeloid antigen CD33 and its specific expression in placentaCytogenetic and Genome Research, 1997
- The Sialoadhesins ? A family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamilyGlycoconjugate Journal, 1996
- CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.The Journal of Experimental Medicine, 1996
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996
- THE USE OF RADIOLABELED ANTI-CD33 ANTIBODY TO AUGMENT MARROW IRRADIATION PRIOR TO MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIATransplantation, 1992
- Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9Hematological Oncology, 1985